Cargando…
Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine
BACKGROUND: Congenital Cytomegalovirus (CMV) infection is an important medical problem that has yet no current solution. A clinical trial of CMV glycoprotein B (gB) vaccine in young women showed promising efficacy. Improved understanding of the basis for prevention of CMV infection is essential for...
Autores principales: | Arav-Boger, Ravit, Wojcik, Genevieve L, Duggal, Priya, Ingersoll, Roxann G, Beaty, Terri, Pass, Robert F, Yolken, Robert H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317442/ https://www.ncbi.nlm.nih.gov/pubmed/22414065 http://dx.doi.org/10.1186/1756-0500-5-140 |
Ejemplares similares
-
Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
por: Pass, Robert F., et al.
Publicado: (2018) -
Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women
por: Murthy, Suchetha, et al.
Publicado: (2011) -
Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase—A Potential Strategy for Suppression of the Wnt Pathway
por: Roy, Sujayita, et al.
Publicado: (2015) -
Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication
por: Kapoor, Arun, et al.
Publicado: (2014) -
Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway
por: Kapoor, Arun, et al.
Publicado: (2016)